Kindness L. Commey
Nishi, 8600082, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Antitumor efficacy and reduced systemic toxicity of palmitic acid-modified pirarubicin nanoparticles in mice.
Journal: Cancer chemotherapy and pharmacology
Published: February 25, 2026
Mechanistic Insights into pH-Responsive Drug Release and Antitumor Effects of an Albumin-Pirarubicin Conjugate.
Journal: Pharmaceutical research
Published: November 19, 2025
Insights into the renal protective effects of 7-phenylheptanoic acid in chronic kidney disease mice: Modulation of indoxyl sulfate production and gut microbiome homeostasis.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: May 27, 2025
The preparation and evaluation of granulated chitosan-catechin tablets with excellent disintegration properties.
Journal: Carbohydrate research
Published: August 02, 2024
7-Phenylheptanoic Acid-Hydroxypropyl β-Cyclodextrin Complex Slows the Progression of Renal Failure in Adenine-Induced Chronic Kidney Disease Mice.
Journal: Toxins
Published: May 22, 2024
Preparation and in Vitro Characterization of Fatty-Acid Modified Pirarubicin Nanosuspensions Stabilized by Albumin.
Journal: Chemical & pharmaceutical bulletin
Published: January 03, 2024
Development of α-Cyclodextrin-Based Orally Disintegrating Tablets for 4-Phenylbutyrate.
Journal: Pharmaceutics
Published: December 20, 2023
Study of the Structural Chemistry of the Inclusion Complexation of 4-Phenylbutyrate and Related Compounds with Cyclodextrins in Solution: Differences in Inclusion Mode with Cavity Size Dependency.
Journal: International journal of molecular sciences
Published: September 19, 2023
Study of the inclusion complexes formed between 4-phenylbutyrate and α-, β- and γ-cyclodextrin in solution and evaluation on their taste-masking properties.
Journal: The Journal of pharmacy and pharmacology
Published: August 10, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026